Search

everythinglearnresearchcommunity

for

Search:↓

Immune checkpoint inhibitors used in cancer therapy can cause hair loss, and understanding this can help manage the side effect.

Using hair dye may slightly increase the risk of non-Hodgkin's lymphoma, especially with long-term use.

Topical minoxidil might potentially cause vision problems, but more research is needed.

Caspase-7 has functions in skin and hair that are not related to cell death.

AMH levels are higher in women with PCOS and can indicate the number of small follicles in their ovaries.

Transverse scalp biopsies are more accurate for diagnosing non-cicatricial alopecia, but examining both types is best for accuracy.

4-O-Methylhonokiol helps protect skin cells from growth-stopping effects of a protein by regulating growth-related pathways.

Gastric bypass surgery improved a woman's hormonal disorder without the need for medication.

Ashwagandha may improve hormone levels and reduce hair loss in non-classical adrenal hyperplasia.

Shorter telomeres in white blood cells may increase the risk of a common type of hair loss.

Treating non-classic congenital adrenal hyperplasia is complex because the benefits of hormone treatment must be weighed against potential health risks.

Regenerative cellular therapies show promise for treating non-scarring hair loss but need more research.

The hair test for vitamin D could be a useful alternative to blood tests, providing a longer-term vitamin D status, but more research is needed.

Both genetics and lifestyle factors contribute to male pattern baldness.

SET7/9 enzyme affects cell growth and diseases like cancer, diabetes, and obesity.

Methotrexate effectively controls eye inflammation in Japanese patients with non-infectious uveitis but requires careful monitoring for side effects.

Non-ablative Er:YAG laser effectively treats hair loss with high patient satisfaction and no side effects.

Non-surgical treatments like thread lifts, PRP therapy, HIFU, and radiofrequency effectively rejuvenate and tighten facial skin.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

Women with certain types of hair loss may have low iron levels, and iron supplements could help.

The document suggests that severe hair loss in SLE patients may be an early sign of scalp DLE, treatable with immunosuppressive therapy.

Two specific SNPs in the TRPS1 gene cause excessive hair growth by altering the protein's structure.

Some women with excess hair growth have a hormone condition that can't be diagnosed by blood or urine tests alone.

Medications for glucose metabolism and weight control, combined therapy options, and herbal medicines may help regulate menstrual cycle in adolescents with PCOS.

Activated and non-activated PRP are equally safe and effective for treating alopecia areata.

The Fatty Liver Index (FLI) may not be enough to rule out non-alcoholic fatty liver disease in lean women with polycystic ovary syndrome.

High uric acid levels are more common in PCOS patients, especially those with androgenic PCOS, and are linked with increased cardiovascular risk and other metabolic issues.

The conclusion is that analyzing RNA from skin oils is a promising way to understand skin diseases.

The article discusses various treatments for different types of non-scarring hair loss.

Women with non-classic congenital adrenal hyperplasia have higher risk for heart and metabolic problems.